Clinical Trial

A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Name: A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases — clinical trial record (NCT07249892)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A multicenter, open-label Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, dosimetry and efficacy of BPR-6023021 in subjects with advanced solid tumors with bone metastases

Trial Details

NCT Number	NCT07249892
Lead Sponsor	Chengdu Syncor Pharmaceutical Co., Ltd. Collaborators: Beijing Quarkxia Technology Co., Ltd.
Conditions	Metastatic Solid Tumors
Enrollment	195 participants
Start Date	2025-11-19
Primary Completion	2027-07-30 (estimated)
Study Completion	2027-09-06 (estimated)
Updated on ClinicalTrials.gov	2025-11-25